Arafura Rare Earths Limited

Peter Sherrington said Nolans has a total funding requirement of USD 1.6 billion, with completion support facilities of USD 280 million, for total funding sources of USD 1.9 billion. He also said approximately USD 134 million remains outstanding, and cash on hand at quarter-end was AUD 570 million, up from AUD 90 million the previous quarter. Arafura completed an AUD 475 million two-tranche placement in October, followed by an associated SPP. The company reported AUD 3.4 million of project development expenditure during the quarter, and Darryl Cuzzubbo said cash burn is a bit over AUD 2 million per month excluding one-off funding-related costs. Forward-looking guidance was for agreements to be finalized by the end of March, enabling a shareholder vote in Q2 and FID thereafter; management said some offtakes only need to be in place by debt drawdown, about 12 months after construction starts.

Darryl Cuzzubbo’s core message was that the macro backdrop for rare earths is strengthening, with China still controlling nearly 90% of global supply and pricing moving higher, including NdPr moving through USD 100/kg on the Asian Metals Index. He framed the company’s strategy as deliberately using the remaining funding/offtake negotiations to secure the best possible long-term terms, even if that takes a bit longer. His tone was confident and patient: FID is close, but management wants to optimize the next decade of value creation through contract pricing.

Peter Sherrington focused on the funding bridge and balance sheet. He said total funding needs are USD 1.6 billion, completion support facilities are USD 280 million, and the quarter ended with AUD 570 million cash on hand, materially higher than AUD 90 million last quarter. He noted credit approvals are current for lenders other than ING, ING has provided a letter of support, and project development spend was AUD 3.4 million in the quarter. He also said the largest FX exposure is converting U.S.-dollar loans back into Australian dollars for project spending.

Analysts and shareholders pressed management on whether FID has been delayed too long, whether the remaining equity could cause further dilution, and whether the share price weakness and prior guidance misses should reduce confidence. Darryl replied that the company is not questioning whether FID will happen, but is optimizing remaining offtake pricing and final equity terms; he said the best guidance is to finalize agreements by end-March, enabling a Q2 shareholder vote. Questions also focused on U.S. floor pricing, Greenland supply, and the German Raw Materials Fund; management said the German package is one of several pathways, the U.S. floor price was viewed as a one-off and the company prefers an independent pricing index, and Greenland remains many years away from commercial production. On the joint venture topic, Darryl said that pathway is not moving fast enough and is no longer the focus.